EcoDrugPlus

Methionyl Aminopeptidase 2

Ensembl ID : ENSG00000111142
Gene: METAP2
Gene Synonyms: MAP2,MNPEP,P67
2 APIs:
4 Enzyme and pathways 7 Cross references
230 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Microtubule Associated Protein Tau

Ensembl ID : ENSG00000186868
Gene: MAPT
Gene Synonyms: DDPAC,FLJ31424,FTDP-17,MAPTL,MGC138549,MSTD,MTBT1,MTBT2,PPND,PPP1R103,TAU,TAU-40,TAU-PHF6
5 APIs:
11 Enzyme and pathways 9 Cross references
226 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Mitogen-Activated Protein Kinase 1

Ensembl ID : ENSG00000100030
Gene: MAPK1
Gene Synonyms: ERK,ERK2,MAPK2,P41MAPK,PRKM1,PRKM2
6 APIs:
163 Enzyme and pathways 9 Cross references
214 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Mitogen-Activated Protein Kinase 11

Ensembl ID : ENSG00000185386
Gene: MAPK11
Gene Synonyms: P38-2,P38BETA,PRKM11,SAPK2
3 APIs:
64 Enzyme and pathways 7 Cross references
201 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Mitogen-Activated Protein Kinase 14

Ensembl ID : ENSG00000112062
Gene: MAPK14
Gene Synonyms: CSBP1,CSBP2,CSPB1,MXI2,P38,PRKM14,PRKM15
35 APIs:
77 Enzyme and pathways 7 Cross references
292 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Mitogen-Activated Protein Kinase 3

Ensembl ID : ENSG00000102882
Gene: MAPK3
Gene Synonyms: ERK1,P44ERK1,P44MAPK,PRKM3
6 APIs:
159 Enzyme and pathways 7 Cross references
199 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Mitogen-Activated Protein Kinase 8

Ensembl ID : ENSG00000107643
Gene: MAPK8
Gene Synonyms: JNK,JNK1,PRKM8,SAPK1
3 APIs:
59 Enzyme and pathways 7 Cross references
292 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Mitogen-Activated Protein Kinase 9

Ensembl ID : ENSG00000050748
Gene: MAPK9
Gene Synonyms: JNK2,P54A,PRKM9,SAPK
3 APIs:
31 Enzyme and pathways 7 Cross references
219 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Mitogen-Activated Protein Kinase Kinase 1

Ensembl ID : ENSG00000169032
Gene: MAP2K1
Gene Synonyms: MAPKK1,MEK1,PRKMK1
20 APIs:
60 Enzyme and pathways 9 Cross references
203 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Mitogen-Activated Protein Kinase Kinase 2

Ensembl ID : ENSG00000126934
Gene: MAP2K2
Gene Synonyms: MEK2,PRKMK2
19 APIs:
35 Enzyme and pathways 9 Cross references
266 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Mitogen-Activated Protein Kinase Kinase Kinase 1

Ensembl ID : ENSG00000095015
Gene: MAP3K1
Gene Synonyms: MAPKKK1,MEKK,MEKK1
1 APIs:
19 Enzyme and pathways 8 Cross references
160 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Mitogen-Activated Protein Kinase Kinase Kinase 10

Ensembl ID : ENSG00000130758
Gene: MAP3K10
Gene Synonyms: MEKK10,MLK2,MST
1 APIs:
7 Cross references
186 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).